RECOMBINANT VIRUS WITH CODON-PAIR DEOPTIMIZED REGION AND USES THEREOF FOR THE TREATMENT OF CANCER

    公开(公告)号:US20210228705A1

    公开(公告)日:2021-07-29

    申请号:US16769102

    申请日:2018-12-21

    申请人: CODAGENIX INC.

    IPC分类号: A61K39/13 A61K39/145 C12N7/00

    摘要: The present invention is the use of designed recombinant viruses for the treatment of various forms of malignant tumors. The recombinant viruses of the invention are those in which one or more regions of the wild type virus was exchanged with a synthetic recoded sequence that reduces the codon pair score relative to human codon pair bias, or that increase the number for CpG di-nucleotides, or that increases the number of UpA di-nucleotides. The method of the present invention is particularly useful for the treatment of malignant tumors in various organs, such as: breast, skin, colon, bronchial passage, epithelial lining of the gastrointestinal, upper respiratory and genito-urinary tracts, liver, prostate and the brain. Astounding remissions in experimental animals have been demonstrated for the treatment of malignant glioblastoma multiforme, as well as for the treatment of breast cancer and melanoma as well.